Pathstone Holdings’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.13M Sell
27,736
-547
-2% -$134K 0.02% 496
2025
Q4
$7.17M Sell
28,283
-1,881
-6% -$472K 0.03% 435
2025
Q3
$7.46M Sell
30,164
-2,979
-9% -$713K 0.03% 434
2025
Q2
$7.96M Sell
33,143
-435
-1% -$101K 0.03% 398
2025
Q1
$7.61M Sell
33,578
-340
-1% -$74.8K 0.03% 424
2024
Q4
$6.98M Sell
33,918
-1,957
-5% -$429K 0.03% 430
2024
Q3
$8.7M Buy
35,875
+283
+0.8% +$66.2K 0.04% 377
2024
Q2
$7.81M Sell
35,592
-392
-1% -$85.2K 0.04% 385
2024
Q1
$8.09M Buy
35,984
+19,018
+112% +$4.29M 0.04% 370
2023
Q4
$3.73M Buy
+16,966
New +$3.59M 0.02% 516

Other funds holding STE

Pathstone Holdings's STE Position: Q1 2026 in Review

Pathstone Holdings reduced its Steris (STE) stake by 1.9% in Q1 2026, selling an estimated $134K and leaving 27,736 shares worth $6.13M. The position accounts for 0.02% of the portfolio, ranked #496.

Pathstone Holdings first reported a position in STE in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.7M in Q3 2024. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Pathstone Holdings held 27,736 shares of Steris worth $6.13M as of Q1 2026.
  • Pathstone Holdings sold 547 Steris shares in Q1 2026, an estimated $134K.
  • Steris made up 0.02% of Pathstone Holdings's portfolio in Q1 2026, its #496 holding.
  • Pathstone Holdings first reported a position in Steris in Q4 2023 and has held it in 10 quarters since.
  • Pathstone Holdings's Steris position peaked at $8.7M in Q3 2024.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.